BMY
Bristol-Myers Squibb·NYSE
--
--(--)
--
--(--)
4.53 / 10
Netural
Capital flows are robust (fund flow score 7.8/10) with net inflows across block, medium, and small sizes, while analyst coverage is split 50/50 between Buy and Neutral, contributing to a Netural sentiment.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-27
InstitutionCitigroup
Times predicted4
Historical Win Rate25.0%
Is money flowing into or out of BMY?
- BMY holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.53/10 (Netural).
